We are live on ! Find out more
IAM

Innovis Asset Management Portfolio holdings

AUM $260M
1-Year Est. Return 28.13%
This Fund
S&P 500
This Quarter Est. Return
-2.3%
1 Year Est. Return
+28.13%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$260M
AUM Growth
-$11.2M
Cap. Flow
-$31.8K
Cap. Flow %
-0.01%
Top 10 Hldgs %
35.09%
Holding
186
New
24
Increased
65
Reduced
40
Closed
33

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$3.74M
2
CRWD icon
CrowdStrike
CRWD
+$3.61M
3
MSFT icon
Microsoft
MSFT
+$3.54M
4
BA icon
Boeing
BA
+$3.39M
5
TSLA icon
Tesla
TSLA
+$2.2M

Top Sells

Rank Stock Value
1
DXCM icon
DexCom
DXCM
+$4.8M
2
SBUX icon
Starbucks
SBUX
+$4.25M
3
PFGC icon
Performance Food Group
PFGC
+$3.22M
4
KO icon
Coca-Cola
KO
+$2.59M
5
P
Everpure Inc
P
+$2.58M

Sector Composition

Rank Sector Weight
1 Technology 30.65%
2 Healthcare 20.01%
3 Financials 9.68%
4 Energy 8.3%
5 Industrials 7.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GPC icon
76
Genuine Parts
GPC
$19B
$416K 0.16%
2,881
+25
+0.9% +$3.88K
UPBD icon
77
Upbound Group
UPBD
$1.12B
$409K 0.16%
13,899
IMUX icon
78
Immunic
IMUX
$210M
$401K 0.15%
27,246
+8,622
+46% +$166K
MLKN icon
79
MillerKnoll
MLKN
$1.58B
$390K 0.15%
+15,948
New +$298K
PRTS icon
80
CarParts.com
PRTS
$55.9M
$377K 0.15%
9,146
NUE icon
81
Nucor
NUE
$56.8B
$372K 0.14%
2,378
+16
+0.7% +$2.65K
KBR icon
82
KBR
KBR
$4.79B
$371K 0.14%
6,302
-12
-0.2% -$739
AXSM icon
83
Axsome Therapeutics
AXSM
$10.4B
$365K 0.14%
5,221
AMAM
84
DELISTED
Ambrx Biopharma Inc
AMAM
$358K 0.14%
31,137
+14,311
+85% +$195K
BFH icon
85
Bread Financial
BFH
$4.06B
$352K 0.14%
10,289
-10
-0.1% -$367
PERI icon
86
Perion Network
PERI
$382M
$352K 0.14%
11,479
-5,567
-33% -$187K
IPG
87
DELISTED
Interpublic Group of Companies
IPG
$349K 0.13%
12,184
+205
+2% +$6.84K
JYNT icon
88
The Joint Corp
JYNT
$119M
$341K 0.13%
+37,919
New +$429K
NRG icon
89
NRG Energy
NRG
$23.4B
$339K 0.13%
8,806
+82
+0.9% +$3.1K
ABT icon
90
Abbott
ABT
$195B
$339K 0.13%
3,500
GOOG icon
91
Alphabet (Google) Class C
GOOG
$4.19T
$338K 0.13%
2,560
MCD icon
92
McDonald's
MCD
$188B
$336K 0.13%
+1,276
New +$364K
DVAX
93
DELISTED
Dynavax Technologies
DVAX
$334K 0.13%
22,581
+7,253
+47% +$102K
SCHX icon
94
Schwab US Large- Cap ETF
SCHX
$74.3B
$327K 0.13%
19,365
-36
-0.2% -$632
CELH icon
95
Celsius Holdings
CELH
$8.35B
$327K 0.13%
5,709
PEP icon
96
PepsiCo
PEP
$193B
$326K 0.13%
1,925
-31
-2% -$5.63K
DOX icon
97
Amdocs
DOX
$6.57B
$324K 0.12%
3,836
+47
+1% +$4.25K
XLRE icon
98
State Street Real Estate Select Sector SPDR ETF
XLRE
$8.38B
$322K 0.12%
9,451
+139
+1% +$5.14K
AIT icon
99
Applied Industrial Technologies
AIT
$11.8B
$322K 0.12%
2,080
MGA icon
100
Magna International
MGA
$17.6B
$316K 0.12%
5,896
+86
+1% +$5.01K

Similar funds

Innovis Asset Management's Q3 2023 Portfolio in Review

As of Q3 2023, Innovis Asset Management held 186 positions worth $260M, down 4.1% from $271M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Innovis Asset Management's Q3 2023 filing shows 24 new, 65 increased, 40 reduced and 33 closed positions. Its largest new stake was Boeing: 15,478 shares worth $2.97M. The largest sale was DexCom, an estimated $4.8M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Healthcare and Financials.

  • Innovis Asset Management's largest Q3 2023 buy was Boeing: 15,478 shares worth $2.97M.
  • Innovis Asset Management added most to Amazon in Q3 2023, an estimated $3.74M increase.
  • Innovis Asset Management's biggest Q3 2023 reduction was Everpure Inc, cutting an estimated $2.58M.
  • Innovis Asset Management fully exited DexCom in Q3 2023, selling an estimated $4.8M.
  • Innovis Asset Management's ten largest holdings make up 35% of its $260M portfolio in Q3 2023.
  • Innovis Asset Management opened 24 new positions and closed 33 in Q3 2023.
  • Innovis Asset Management's portfolio value fell 4.1% quarter-over-quarter to $260M.

Based on Innovis Asset Management's 13F filing for Q3 2023, filed 9 Nov 2023.